News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Schmid John P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| Schmid John P. (Director) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Granted 19,650 shares
@ $0
Granted 27,350 options to buy
@ $2.47, valued at
$67.6k
|
|
| 06/07/2023 |
4
| Schmid John P. (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 42,500 shares
@ $0 |
|
| 06/02/2023 |
4
| Schmid John P. (Director) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $5.63, valued at
$84.5k
|
|
| 01/10/2023 |
4
| Schmid John P. (Director) has filed a Form 4 on ANAPTYSBIO, INC|
Txns:
| Granted 10,600 options to buy
@ $23.23, valued at
$246.2k
Granted 3,900 restricted stock units
@ $0 |
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Schmid John P. (Director) has filed a Form 4 on ANAPTYSBIO, INC|
Txns:
| Granted 9,200 options to buy
@ $30.44, valued at
$280k
|
|
| 10/05/2021 |
4
| Schmid John P. (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 5,659 shares
@ $0
Granted 25,220 options to buy
@ $12.5, valued at
$315.3k
Granted 20,000 options to buy
@ $10, valued at
$200k
Granted 11,228 options to buy
@ $4.68, valued at
$52.5k
Granted 11,228 options to buy
@ $3.9, valued at
$43.8k
|
|
| 10/05/2021 |
4
| Schmid John P. (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Disposed/sold 5,659 shares
@ $0
Disposed/sold 25,220 options to buy
@ $12.5, valued at
$315.3k
Disposed/sold 20,000 options to buy
@ $10, valued at
$200k
Disposed/sold 11,228 options to buy
@ $4.68, valued at
$52.5k
Disposed/sold 11,228 options to buy
@ $3.9, valued at
$43.8k
|
|
| 07/26/2021 |
4
| Schmid John P. (Director) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Granted 25,833 options to buy
@ $8.63, valued at
$222.9k
|
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Schmid John P. (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Granted 11,228 options to buy
@ $3.9, valued at
$43.8k
|
|
| 03/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| Schmid John P. (Director) has filed a Form 4 on ANAPTYSBIO, INC|
Txns:
| Granted 11,000 options to buy
@ $29.7, valued at
$326.7k
|
|
| 07/13/2020 |
4
| Schmid John P. (Director) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $16, valued at
$320k
|
|
| 06/11/2020 |
4
| Schmid John P. (Director) has filed a Form 4 on Neos Therapeutics, Inc.|
Txns:
| Granted 23,453 shares
@ $0 |
|
| 06/04/2020 |
4
| Schmid John P. (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Granted 11,228 options to buy
@ $4.68, valued at
$52.5k
|
|
| 02/13/2020 |
4
| Schmid John P. (Director) has filed a Form 4 on ANAPTYSBIO, INC|
Txns:
| Granted 11,000 options to buy
@ $16.56, valued at
$182.2k
|
|
| 06/17/2019 |
4
| Schmid John P. (Director) has filed a Form 4 on Neos Therapeutics, Inc.|
Txns:
| Granted 46,907 options to buy
@ $1.44, valued at
$67.5k
|
|
| 03/01/2019 |
4
| Schmid John P. (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Granted 20,000 options to buy
@ $10, valued at
$200k
|
|
| 02/11/2019 |
4
| Schmid John P. (Director) has filed a Form 4 on ANAPTYSBIO INC|
Txns:
| Granted 6,000 options to buy
@ $68.89, valued at
$413.3k
|
|
| 07/03/2018 |
4
| Schmid John P. (Director) has filed a Form 4 on Neos Therapeutics, Inc.|
Txns:
| Granted 22,756 options to buy
@ $6.05, valued at
$137.7k
|
|
| 02/06/2018 |
4
| Schmid John P. (Director) has filed a Form 4 on ANAPTYSBIO INC|
Txns:
| Granted 6,000 options to buy
@ $104.81, valued at
$628.9k
|
|
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/28/2017 |
4
| Schmid John P. (Director) has filed a Form 4 on ANAPTYSBIO INC|
Txns:
| Granted 15,000 options to buy
@ $24.6, valued at
$369k
|
|
| 07/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/06/2015 |
4
| Schmid John P. (CFO) has filed a Form 4 on Auspex Pharmaceuticals, Inc.|
Txns:
| Unknown transaction of 144,444 shares
@ $0
Disposed/sold 59,026 options to buy
@ $6.57, valued at
$387.8k
Disposed/sold 30,000 options to buy
@ $59.66, valued at
$1.8M
Disposed/sold 15,000 restricted stock units
@ $0 |
|
| 02/04/2015 |
4
| Schmid John P. (CFO) has filed a Form 4 on Auspex Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $59.66, valued at
$1.8M
Granted 15,000 restricted stock units
@ $0 |
|
| 09/13/2013 |
4
| Schmid John P. (CFO) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Disposed/sold 107,639 shares
@ $0
Disposed/sold 28,720 options to buy
@ $1.29, valued at
$37k
Disposed/sold 8,138 options to buy
@ $1.29, valued at
$10.5k
Disposed/sold 75,000 options to buy
@ $3.5, valued at
$262.5k
Disposed/sold 85,000 options to buy
@ $4.8, valued at
$408k
Disposed/sold 140,000 options to buy
@ $6.13, valued at
$858.2k
|
|
| 03/11/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/25/2012 |
4
| Schmid John P. (CFO and Secretary) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Sold 1,800 shares
@ $6, valued at
$10.8k
|
|
| 03/28/2012 |
4
| Schmid John P. (CFO and Secretary) has filed a Form 4 on Trius Therapeutics Inc|
Txns:
| Exercised 5,000 options to buy
@ $1.29, valued at
$6.5k
|
|
|
|
|